• Cancer Drugs Are The Least Likely to Receive FDA Approval

    A massive new study of drug candidates sheds light on which experimental therapies are most likely to eventually reach the market. The report was compiled by biotech’s largest trade association, the Biotechnology Innovation Organization (BIO), with the help of business intelligence firms BioMedTracker and Amplion, and it found that drugs for blood disorders have the highest probability of ultimately winning FDA approval. Meanwhile, cancer drugs have the lowest chance of receiving the go-ahead. BIO&r

  • A Tale of Two Gluts: Oil and Ore Approach $50 on Opposite Paths

    Crude oil and iron ore are two of the world’s most important industrial commodities, where supply and demand are tied to the fate of the global economy. Yet, they’re doing very different things right now. Oil in London traded above $50 a barrel for the first time since November, while iron is moving in the opposite direction and looks set to fall below $50 a ton any day. It’s a slightly artificial comparison -- there’s little physical equivalence between a barrel of oil and a ton of o

  • Celgene, Gilead Said to Join Suitors Mulling Medivation Bids

    Biotechnology companies Celgene Corp. and Gilead Sciences Inc. are considering bids for Medivation Inc., which would pitch them against suitors led by French drugmaker Sanofi, according to people familiar with the matter. Celgene and Gilead are talking to advisers as they evaluate whether to pursue a bid for the cancer-therapy company, the people said, asking not to be identified because the deliberations are private. No formal sales process is under way yet and Celgene and Gilead could decide against m

  • Chinese Company Searching for Billion-Dollar Oil Deals in Texas

    China’s Yantai Xinchao Industry Co. is pursuing U.S. oil acquisitions worth as much as $1 billion in the Permian Basin, and it won’t be satisfied letting others run the show, according to the head of the company’s U.S. subsidiary. Unlike other Asian companies that bought stakes in U.S. energy prospects in recent years, Xinchao is seeking so-called operated positions, or deals that give it primary authority over everything from how deep to drill to how intensively to frack each well, said Cu

  • Oncolys in license deal with Jiangsu Hengrui on OBP-301

    Tokyo-based Oncolys BioPharma has agreed to license China rights of its oncolytic virus candidate, OBP-301, to Jiangsu Hengrui Medicine for a therapy area that saw a first-in-class approval for Amgen's ($AMGN) Imlygic (talimogene laherparepvec) by the U.S. FDA last year. In a release, Oncolys said the board approved a binding letter-of-intent with Lianyungang-based Jiangsu Hengrui Medicine for the candidate known as telomelysin "to pave the way

  • Oil Rebound Has Citigroup Seeing Worst Over for Commodities

    The commodities market has turned a corner and prices are unlikely to return to lows seen in the first quarter, according to Citigroup Inc., which boosted forecasts from metals to grains amid an oil-led recovery. The bottom was likely hit earlier this year when weak fundamentals across all commodities were reinforced by selling after the collapse of China’s equity markets, Citigroup analysts including Ed Morse wrote in a report Tuesday. The bank is now predicting Brent oil will climb to $50 a barrel in

Investment Opportunities


The hidden gems in CSE

From the old days of Vancouver Stock Exchange (VSE) of Howe Street, to being combined... Full Story

Industry News More

Nautilus underwater project in Eastern Pacific richer than thought

Canadian seafloor miner Nautilus Minerals (TSX, LON:NUS) posted Thursday upgraded mineral resource estimates for its underwater mining project in the Eastern Pacific, off the coast of Mex... Full Story

Sibanye’s platinum mine workers begin indefinite strike

Oil slips for second day as $50 level sparks new output fears

Gold Posts Another Losing Week as Yellen Adds to Rate-Rise Angst

Gold Imports by China Decline as Property Revival Damps Demand

Miner Sees Silver Price Surging Ninefold as Global Gadgets Boom

Trading the Oil Rally: 4 Names to Watch

Shale Oil Seen Stifling OPEC’s Classic Market-Balancing Role

A Tale of Two Gluts: Oil and Ore Approach $50 on Opposite Paths

Zinc Leads Industrial Metals Higher After Oil Pushes Above $50

Press Release More


 is pleased to announce that it has completed the construction of its new 300tpd Veta Dorada ore processing plant and has begun the commissioning process.  The Veta Dorada plant... Full Story

Diamcor Provides Update on Krone-Endora at Venetia Project Progress

Manitok Energy Inc. Announces Closing Of The First Tranche Of Its Brokered Private Placement

Avino closes U.S. brokered public offering

Avino arranges U.S. brokered public offering of shares

Serengeti Announces Signing of Binding Agreement with Daewoo International Corp. for Kwanika Project

Other Industry News

Life Science More

Cancer Drugs Are The Least Likely to Receive FDA Approval

Valeant Rejected Takeover Bid From Takeda and TPG, WSJ Says

This Drug Company's Shares Are Up 20% Today

Celgene, Gilead Said to Join Suitors Mulling Medivation Bids

Resverlogix Presents New Complement Data and Establishes Renal Clinical Advisory Board at the 53rd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA)

Technology More

Chinese Rail Giant to Raise Up to $1.8 Billion in Share Sale

Will Twilio reopen tech IPO window?

Snapchat Valued at $18 Billion in Funding Round

Ant Financial Seeks Licenses in Asia as Global Push Accelerates

China's Huawei sues Samsung Electronics claiming mobile patent infringement

CSE Center More

MGX Minerals Reports Control Over Majority of High Grade Lithium (>=90mg/L) in Alberta - Engages APEX Geoscience for N.I. 43-101 Technical Report

MGX Minerals Issues Clarification of Previously Issued Technical Disclosure

PUDO Inc. - The Canadian Tech Startup Revolutionizing the E-commerce Delivery Infrastructure

MGX Minerals Completes Haul Road – Advances Bulk Sample at Driftwood Creek Magnesium

MGX Minerals Announces Debt Settlement and Option Grant

Experts Column More

05.25 - The Morning Call: Markets don’t believe the Bull

Like MacDonald's all day breakfast we had an all day rally yesterday. Most traders when asked... Read More

05.24 - The Morning Call: The Technicals break down

The Dow and the S&P 500 have broken down below their 50 DMA. This is not good. We look mo... Read More

05.18 - The Morning Call: We are getting FED up with the Chatter

The FOMC minutes will be released at 2pm today. Traders were positioning in front of that by ... Read More

NAI Interview More

Interviews with Jon Stern, CEO of Cohbar Inc.

NAI500 is delighted to spend some time with the CEO of Cohbar Inc. (TSXV:COB.U), one of the emerg... Read More

Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey

The evidence is mounting: Resverlogix Corp.'s first-in-class, epigenetics-based drug cand... Read More

Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital's Eden Rahim

Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. Tha... Read More

NAI Reports More

One Chinese group exits, more Chinese groups enter

The year of 2015 completed with a flurry of deals and news that trigger our thoughts for what to look for in 2016.  While the volatility of Chinese stock market still very much i... Read More

Oil Buying Opportunities for China: Canada to Look to China to Sell Oil after Obama Rejects Keystone XL Pipeline

NAI500 comment: ——Obama has formally rejected the Keystone XL Pipeline proposal which would have built a 1,179 mile crude oil pipeline from Canada to US refineries. &mda... Read More

Lessons from Australia and China’s Healthcare Cooperation: What Can Canadian Firms Learn?

NAI500 Comments: i. The Chinese government is heavily focused on the health of its citizens as shown by its decision to build 7,500 public hospitals through the private sector over the... Read More

Upcoming Events More

Company Search

Global Search

Selected Companies More

Gainey Capital Corp

Gainey Capital Corp. is a well-funded, cash-flow positive gold and silver exploration company tha...

Rock Energy Inc

Rock Energy Inc is engaged in the exploration, development and production of crude oil and natura...

Imprimis Pharmaceuticals Inc

Imprimis Pharmaceuticals is a specialty pharmaceutical company focused on the development and com...

Stock Index Chart

NAI 500 Company Movers

NAI 500 Volume Leaders

Symbol Closing Price Change% Vol(k)
LSG 2.08 +8.33% 12,327
FM 8.92 +2.29% 6,164
IMG 4.14 --5.26% 4,021
Symbol Closing Price Change% Vol(k)
TBE 0.07 --7.14% 2,581
SGY 2.41 --0.16% 1,468
SUO 0.11 +10.00% 1,351
Symbol Closing Price Change% Vol(k)
PTX 0.44 --2.81% 3,990
NSPH 1.69 --0.59% 3,573
BIOD 0.33 --9.40% 2,121
Symbol Closing Price Change% Vol(k)
VMEM 0.42 +24.19% 4,160
OCLR 4.99 +1.01% 1,644
GLUU 2.39 +0.00% 1,437

NAI 500 Percent Gainers

Symbol Closing Price Change% Vol(k)
NAR 0.17 +30.77% 53
NPK 0.37 +21.31% 5
FRO 0.13 +19.05% 70
Symbol Closing Price Change% Vol(k)
SXE 0.04 +16.67% 10
SFD 1.50 +15.38% 3
MTE 0.56 +12.00% 139
Symbol Closing Price Change% Vol(k)
KNE 0.04 +16.67% 65
GEN 0.18 +12.50% 239
CRH 4.37 +9.52% 484
Symbol Closing Price Change% Vol(k)
SPDC 0.10 +143.90% 59
DSY 0.35 +29.63% 7
VMEM 0.42 +24.19% 4,160

Top Hits News


Chinese English